Rhumbline Advisers Buys 84,573 Shares of agilon health, inc. (NYSE:AGL)

Rhumbline Advisers raised its stake in shares of agilon health, inc. (NYSE:AGL) by 24.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 433,019 shares of the company’s stock after purchasing an additional 84,573 shares during the quarter. Rhumbline Advisers owned 0.11% of agilon health worth $2,832,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Scotia Capital Inc. lifted its holdings in shares of agilon health by 1.3% during the 4th quarter. Scotia Capital Inc. now owns 132,576 shares of the company’s stock worth $1,664,000 after acquiring an additional 1,741 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its position in agilon health by 31.5% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock valued at $113,000 after purchasing an additional 2,149 shares in the last quarter. Swiss National Bank raised its position in agilon health by 0.6% during the first quarter. Swiss National Bank now owns 602,800 shares of the company’s stock valued at $3,677,000 after purchasing an additional 3,400 shares in the last quarter. Quest Partners LLC bought a new stake in agilon health during the fourth quarter worth about $45,000. Finally, J.Safra Asset Management Corp boosted its holdings in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after purchasing an additional 3,625 shares in the last quarter.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on AGL. Truist Financial raised their price objective on agilon health from $6.40 to $6.50 and gave the company a “hold” rating in a report on Friday, May 24th. Baird R W raised shares of agilon health to a “hold” rating in a research note on Thursday, May 30th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Evercore ISI increased their target price on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a report on Tuesday, July 9th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, agilon health currently has a consensus rating of “Hold” and a consensus target price of $8.57.

agilon health Stock Up 9.9 %

Shares of NYSE:AGL opened at $4.00 on Thursday. The firm has a market capitalization of $1.65 billion, a P/E ratio of -5.71 and a beta of 0.54. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a 50 day moving average price of $5.26 and a 200-day moving average price of $5.55. agilon health, inc. has a 52-week low of $3.07 and a 52-week high of $20.37.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business’s revenue was up 38.7% on a year-over-year basis. During the same period last year, the business earned ($0.04) earnings per share. As a group, equities research analysts anticipate that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Steven Sell bought 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.20% of the stock is currently owned by corporate insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.